Skip to main content

Table 2 Characteristics of lesions

From: 90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer

 

Min

Q1

Median

Q3

Max

Baseline TLG (g)

10

36

71

165

1228

Baseline SUVpeak (g/ml)

3

5

6

8

13

Follow-up TLG (g)

0

0

7

61

5115

Follow-up SUVpeak (g/ml)

1

3

4

5

14

TLG-decrease (%)

− 1116

8

96

100

100

SUVpeak-decrease (%)

− 45

11

43

57

91

Lesion mean absorbed dose (Gy)

8

39

55

89

268